HIV Self Testing Market Size, Share, Trends & Analysis By Type, Regional Outlook, Industry Insights, Key Players, Applications And Forecast To 2028

  • Category:Pharmaceuticals & Healthcare
  • Published on:Feb 2020
  • Pages:100
  • Formats:
  • Report Code:22282

Report Summary

Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global HIV Self Testing market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.

HIV Self Testing market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

To learn more about this report

Request For Sample

Key Research Highlights: Market Drivers

The HIV Self Testing market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the HIV Self Testing products across developed and developing countries of the world.

Key Research Highlights: Market Restrains

Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of HIV Self Testing products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the HIV Self Testing market.

To learn more about this report

Request For Sample

Key Research Highlights: Trends

Increasing research and development spending on HIV Self Testing development has been the leading industry trend of HIV Self Testing market

The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.

Global HIV Self Testing Market Size, 2018-2028 (USD MILLION)

To learn more about this report

Request For Sample

Market Segmentation

Report Attributes Details
The market size value in 2021 USD XX.XX Million
CAGR (2021 - 2028) XX.XX %
The Revenue forecast in 2028 USD XX.XX Million
Base year for estimation 2021
Historical data 2018-2019
Forecast period 2022-2028
Quantitative units
  • Revenue in USD Million
  • CAGR from 2021 to 2028
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered By Type Outlook, Application Outlook, Regional Outlook
By Type Outlook Blood, Oral Fluid, Urine, Other
By Application Outlook 2nd, 3rd, 4th, Other
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scope U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey
Key companies profiled Atomo Diagnostics, BioSURE United Kingdom, Ltd., Biosynex Group, bioLytical Laboratories, OraSure Technologies, Inc., Chembio Diagnostic Systems, Inc., Orangelife Com�rcio e Ind�stria LTDA, Bedford Biotech Nigeria, Sedia Biosciences Corporation
Customization Available Yes, the report can be tailored to meet your specific requirements.

Key Market Players

  • Atomo Diagnostics
  • BioSURE United Kingdom
  • Ltd.
  • Biosynex Group
  • bioLytical Laboratories
  • OraSure Technologies
  • Inc.
  • Chembio Diagnostic Systems
  • Inc.
  • Orangelife Com�rcio e Ind�stria LTDA
  • Bedford Biotech Nigeria
  • Sedia Biosciences Corporation

HIV Self Testing Market, By Type

  • Blood
  • Oral Fluid
  • Urine
  • Other

HIV Self Testing Market, By Application

  • 2nd
  • 3rd
  • 4th
  • Other

Key Benefits To The Stake Holders

  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Table Of Contents

Table of Contents

Global HIV Self Testing Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 HIV Self Testing Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Blood Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Oral Fluid Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Urine Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific HIV Self Testing Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America HIV Self Testing Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe HIV Self Testing Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America HIV Self Testing Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa HIV Self Testing Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World HIV Self Testing Market Assessment by Type
8.1 Asia Pacific HIV Self Testing Market Assessment by Application (Consumption and Market Share)
8.2 North America HIV Self Testing Market Assessment by Application (Consumption and Market Share)
8.3 Europe HIV Self Testing Market Assessment by Application (Consumption and Market Share)
8.4 South America HIV Self Testing Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa HIV Self Testing Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Atomo Diagnostics
9.1.1 Atomo Diagnostics Profiles
9.1.2 Atomo Diagnostics Product Portfolio
9.1.3 Atomo Diagnostics HIV Self Testing Business Performance
9.1.4 Atomo Diagnostics HIV Self Testing Business Development and Market Status
9.2 BioSURE United Kingdom, Ltd.
9.2.1 BioSURE United Kingdom, Ltd. Profiles
9.2.2 BioSURE United Kingdom, Ltd. Product Portfolio
9.2.3 BioSURE United Kingdom, Ltd. HIV Self Testing Business Performance
9.2.4 BioSURE United Kingdom, Ltd. HIV Self Testing Business Development and Market Status
9.3 Biosynex Group
9.3.1 Biosynex Group Profiles
9.3.2 Biosynex Group Product Portfolio
9.3.3 Biosynex Group HIV Self Testing Business Performance
9.3.4 Biosynex Group HIV Self Testing Business Development and Market Status
9.4 bioLytical Laboratories
9.4.1 bioLytical Laboratories Profiles
9.4.2 bioLytical Laboratories Product Portfolio
9.4.3 bioLytical Laboratories HIV Self Testing Business Performance
9.4.4 bioLytical Laboratories HIV Self Testing Business Development and Market Status
9.5 OraSure Technologies, Inc.
9.5.1 OraSure Technologies, Inc. Profiles
9.5.2 OraSure Technologies, Inc. Product Portfolio
9.5.3 OraSure Technologies, Inc. HIV Self Testing Business Performance
9.5.4 OraSure Technologies, Inc. HIV Self Testing Business Development and Market Status
9.6 Chembio Diagnostic Systems, Inc.
9.6.1 Chembio Diagnostic Systems, Inc. Profiles
9.6.2 Chembio Diagnostic Systems, Inc. Product Portfolio
9.6.3 Chembio Diagnostic Systems, Inc. HIV Self Testing Business Performance
9.6.4 Chembio Diagnostic Systems, Inc. HIV Self Testing Business Development and Market Status
9.7 Orangelife Comércio e Indústria LTDA
9.7.1 Orangelife Comércio e Indústria LTDA Profiles
9.7.2 Orangelife Comércio e Indústria LTDA Product Portfolio
9.7.3 Orangelife Comércio e Indústria LTDA HIV Self Testing Business Performance
9.7.4 Orangelife Comércio e Indústria LTDA HIV Self Testing Business Development and Market Status
9.8 Bedford Biotech Nigeria
9.8.1 Bedford Biotech Nigeria Profiles
9.8.2 Bedford Biotech Nigeria Product Portfolio
9.8.3 Bedford Biotech Nigeria HIV Self Testing Business Performance
9.8.4 Bedford Biotech Nigeria HIV Self Testing Business Development and Market Status
9.9 Sedia Biosciences Corporation
9.9.1 Sedia Biosciences Corporation Profiles
9.9.2 Sedia Biosciences Corporation Product Portfolio
9.9.3 Sedia Biosciences Corporation HIV Self Testing Business Performance
9.9.4 Sedia Biosciences Corporation HIV Self Testing Business Development and Market Status
10 World HIV Self Testing Market Assessment by Players
10.1 Global HIV Self Testing Sales (K Units) and Market Share by Players 2014-2020
10.2 Global HIV Self Testing Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global HIV Self Testing Price (USD/Unit) of Players 2014-2020
10.4 Global HIV Self Testing Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America HIV Self Testing Sales Assessment of Players 2014-2020
11.1.2 North America HIV Self Testing Revenue Assessment of Players 2014-2020
11.1.3 North America HIV Self Testing Price Assessment of Players 2014-2020
11.1.4 North America HIV Self Testing Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe HIV Self Testing Sales Assessment of Players 2014-2020
11.2.2 Europe HIV Self Testing Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe HIV Self Testing Price Assessment of Players 2014-2020
11.2.4 Europe HIV Self Testing Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific HIV Self Testing Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific HIV Self Testing Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific HIV Self Testing Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific HIV Self Testing Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America HIV Self Testing Sales Assessment of Players 2014-2020
11.4.2 South America HIV Self Testing Revenue Assessment of Players 2014-2020
11.4.3 South America HIV Self Testing Price Assessment of Players 2014-2020
11.4.4 South America HIV Self Testing Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa HIV Self Testing Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa HIV Self Testing Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa HIV Self Testing Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa HIV Self Testing Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific HIV Self Testing Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific HIV Self Testing Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific HIV Self Testing Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America HIV Self Testing Sales by Countries/Regions 2014-2020
12.2.2 North America HIV Self Testing Revenue by Countries/Regions 2014-2020
12.2.3 North America HIV Self Testing Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe HIV Self Testing Sales by Countries/Regions 2014-2020
12.3.2 Europe HIV Self Testing Revenue by Countries/Regions 2014-2020
12.3.3 Europe HIV Self Testing Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America HIV Self Testing Sales by Countries/Regions 2014-2020
12.4.2 South America HIV Self Testing Revenue by Countries/Regions 2014-2020
12.4.3 South America HIV Self Testing Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa HIV Self Testing Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa HIV Self Testing Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa HIV Self Testing Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World HIV Self Testing Sales & Revenue Forecast 2021-2026
14.1 World HIV Self Testing Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World HIV Self TestingSales and Market Share by Regions
14.1.2 World HIV Self TestingRevenue and Market Share by Regions
15 Asia HIV Self Testing Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Blood
15.1.2 Oral Fluid
15.1.3 Urine
15.2 Consumption Forecast by Application, 2021-2026
16 North America HIV Self Testing Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Blood
16.1.2 Oral Fluid
16.1.3 Urine
16.2 Consumption Forecast by Application, 2021-2026
17 Europe HIV Self Testing Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Blood
17.1.2 Oral Fluid
17.1.3 Urine
17.2 Consumption Forecast by Application, 2021-2026
18 South America HIV Self Testing Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Blood
18.1.2 Oral Fluid
18.1.3 Urine
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa HIV Self Testing Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Blood
19.1.2 Oral Fluid
19.1.3 Urine
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global HIV Self Testing Price (USD/Unit) Trend 2021-2026
20.2 Global HIV Self Testing Gross Profit Trend 2021-2026
21 Conclusion


Choose License Type

close

categories